| Inbound Relationships | 
Type | 
Active | 
Source | 
Characteristic | 
Refinability | 
Group | 
| Eye drops suspension | 
Is a | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| tobramycin 0,3 %/fluorometolon 0,1 %, ögonsuspension | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| nepafenak 1 milligram/milliliter, suspension för oftalmiskt bruk | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| levobetaxololhydroklorid 0,5 %, suspension för oftalmiskt bruk | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| prednisolonacetat 25 mg/ml, suspension | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Prednisolone acetate 1.25 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Prednisolone acetate 10 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Medrysone 10 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely prednisolone acetate 1.2 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Loteprednol etabonate 5 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| tetracyklinhydroklorid 1 % vikt/volym, suspension | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Besifloxacin 6 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Difluprednate 500 microgram/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Levobetaxolol 5 mg/mL eye suspension | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| betaxololhydroklorid 2,5 milligram/milliliter, suspension för oftalmiskt bruk | 
Has manufactured dose form | 
False | 
Eye suspension | 
Inferred relationship | 
Some | 
  | 
| Product containing precisely ciclosporin 500 microgram/1 milliliter conventional release eye suspension (clinical drug) | 
Has manufactured dose form | 
True | 
Eye suspension | 
Inferred relationship | 
Some | 
  |